Bioethics 35 (9):947-955 (2021)
AbstractAs we combat the COVID-19 pandemic, both the prescription of antimicrobials and the use of biocidal agents have increased in many countries. Although these measures can be expected to benefit existing people by, to some extent, mitigating the pandemic's effects, they may threaten long-term well-being of existing and future people, where they contribute to the problem of antimicrobial resistance (AMR). A trade-off dilemma thus presents itself: combat COVID-19 using these measures, or stop using them in order to protect against AMR. Currently, I argue, we are choosing to continue with these measures, and thus to prioritize combatting COVID-19, without adequate ethical reflection on the AMR-associated costs of these measures. I discuss the magnitude of the possible costs and benefits involved in making the trade-off in favour of COVID-19, and their distribution. I highlight two salient aspects of distribution that can help determine whether combatting COVID-19 whilst exacerbating AMR produces justly distributed costs and benefits: distribution between current and future populations, and distribution between existing geographical populations. Adopting this account, I argue that based on the magnitude and distribution of costs and benefits of combatting COVID-19, we have good reason to rethink this trade-off, and instead consider prioritizing protecting current and future people against AMR, but jettisoning measures against COVID-19 that also exacerbate AMR.
Similar books and articles
A Trade‐Off: Antimicrobial Resistance and COVID‐19.Tess Johnson - 2021 - Bioethics 1 (1):1-9.
Foreign Trade Agricultural Products of Ukraine During COVID-19 Pandemic.Olesia Bezpartochna, Igor Britchenko & Maksym Bezpartochnyi - 2020 - In Сборник с доклади, представени на кръгла маса на тема „Външна търговия и пандемия“. Sofia, Bułgaria: pp. 169-179.
Antimicrobial Footprints, Fairness, and Collective Harm.Anne Schwenkenbecher - 2020 - In Euzebiusz Jamrozik & Michael Selgelid (eds.), Ethics and Drug Resistance: Collective Responsibility for Global Public Health. Springer. pp. 379-389.
Evaluating the Risks of Public Health Programs: Rational Antibiotic Use and Antimicrobial Resistance.Annette Rid, Jasper Littmann & Alena Buyx - 2019 - Bioethics 33 (7):734-748.
Addressing the Burden of Antimicrobial Resistance in Vietnamese Hospitals.Dat Vu Quoc - 2020 - Dissertation, The Open University
Antimicrobial Resistance and Antimicrobial Stewardship Programmes: Benefiting the Patient or the Population?Alberto Giubilini - 2017 - Journal of Medical Ethics 43 (10):653-654.
Resistance to Narratives of the Covid‐19 Pandemic as an Act of God.Zara Thokozani Kamwendo - 2021 - Zygon 56 (4):1110-1129.
The International Dimensions of Antimicrobial Resistance: Contextual Factors Shape Distinct Ethical Challenges in South Africa, Sri Lanka and the United Kingdom.Eva M. Krockow & Carolyn Tarrant - 2019 - Bioethics 33 (7):756-765.
How Law Can Help Solve the Collective Action Problem of Antimicrobial Resistance.Steven J. Hoffman, Reema Bakshi & Susan Rogers Van Katwyk - forthcoming - Bioethics.
Difficult Trade-Offs in Response to COVID-19: The Case for Open and Inclusive Decision-Making.Ole Frithjof Norheim, Joelle Abi-Rached, Liam Kofi Bright, Kristine Baeroe, Octavio Ferraz, Siri Gloppen & Alex Voorhoeve - 2021 - Nature Medicine 27:10-13.
Articulations of Antimicrobial Resistance in Trade Union Financed Journals for Nurses in Scandinavia – A Foucauldian Perspective.Stinne Glasdam, Henrik Loodin & Jonas Wrigstad - forthcoming - Nursing Inquiry.
Antimicrobial Stewardship Programmes: Bedside Rationing by Another Name?Simon Oczkowski - 2017 - Journal of Medical Ethics 43 (10):684-687.
Combating Resistance: The Case for a Global Antibiotics Treaty.Jonny Anomaly - 2010 - Public Health Ethics 3 (1):13-22.
Distributional Considerations in Economic Responses to Antimicrobial Resistance.Joanna Coast & Richard D. Smith - 2015 - Public Health Ethics 8 (3):225-237.
Antibiotic Resistance as a Tragedy of the Commons: An Ethical Argument for a Tax on Antibiotic Use in Humans.Alberto Giubilini - 2019 - Bioethics 33 (7):776-784.
Added to PP
Historical graph of downloads
Citations of this work
Justifying the More Restrictive Alternative: Ethical Justifications for One Health AMR Policies Rely on Empirical Evidence.Tess Johnson & William Matlock - forthcoming - Public Health Ethics.
References found in this work
No references found.